Tower Research Capital LLC (Trc) Provention Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$6.7 - $24.21 $90,805 - $328,118	13,553 Added 3614.13%	13,928 $336,000
Q4 2022 Feb 10, 2023	SELL	$4.52 - $10.57 $118,261 - $276,553	-26,164 Reduced 98.59%	375 $4,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.62 $62,357 - $102,171	18,180 Added 217.49%	26,539 $119,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $7,427 - $14,855	2,035 Added 32.18%	8,359 $33,000
Q1 2022 May 12, 2022	BUY	$3.4 - $7.88 $4,688 - $10,866	1,379 Added 27.89%	6,324 $46,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $3,309 - $4,374	592 Added 13.6%	4,945 $28,000
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $2,931 - $4,314	518 Added 13.51%	4,353 $28,000
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $86,746 - $142,725	-12,928 Reduced 77.12%	3,835 $32,000
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $136,184 - $261,738	13,457 Added 407.05%	16,763 $176,000
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $435,581 - $699,738	-36,945 Reduced 91.79%	3,306 $56,000
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $394,439 - $579,834	38,147 Added 1813.07%	40,251 $516,000
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $16,432 - $35,768	2,104 New	2,104 $30,000
Q1 2020 May 15, 2020	SELL	$5.42 - $17.75 $39,571 - $129,592	-7,301 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.84 - $14.9 $75,008 - $191,375	-12,844 Reduced 63.76%	7,301 $109,000
Q3 2019 Nov 05, 2019	BUY	$6.83 - $13.0 $137,590 - $261,885	20,145 New	20,145 $137,000
Q2 2019 Aug 13, 2019	SELL	$2.3 - $13.79 $2,208 - $13,238	-960 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.97 - $2.57 $4,446 - $5,800	-2,257 Reduced 70.16%	960 $2,000
Q4 2018 Feb 14, 2019	SELL	$1.73 - $4.0 $3,382 - $7,820	-1,955 Reduced 37.8%	3,217 $6,000
Q3 2018 Nov 13, 2018	BUY	$3.4 - $4.81 $17,584 - $24,877	5,172 New	5,172 $21,000

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account